Uterine fibroids (leiomyoma) - Symptoms, Causes, Treatment & Prevention

📅 Updated: June 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Uterine Fibroids (Leiomyoma) – Comprehensive Medical Guide

Overview

Uterine fibroids, also called leiomyomas or myomas, are non‑cancerous (benign) smooth‑muscle tumors that develop in the wall of the uterus. They can vary in size from a few millimeters to large masses that distort the uterine shape. Fibroids are the most common benign tumor of the female reproductive tract.

Who is affected? Fibroids can occur at any age after menarche, but they are most prevalent during the reproductive years (30‑50 years). Up to 70–80 % of women will develop fibroids by age 50, although many remain asymptomatic and are discovered incidentally during routine imaging.1

Prevalence by ethnicity—African‑American women develop fibroids earlier, tend to have larger and more numerous growths, and are 2–3 times more likely to require surgical treatment compared with white women.2

Symptoms

Most fibroids are “silent,” but when symptoms appear they can affect daily life. The spectrum depends on fibroid size, number, and location (submucosal, intramural, subserosal, or pedunculated).

  • Heavy or prolonged menstrual bleeding (menorrhagia) – often leads to anemia.
  • Painful periods (dysmenorrhea) – cramping that may worsen over time.
  • Pelvic pressure or fullness – a sensation of heaviness, especially when lying down.
  • Pelvic pain – can be constant or intermittent; may radiate to the lower back or thighs.
  • Frequent urination – pressure on the bladder.
  • Difficulty emptying the bladder – urinary retention in severe cases.
  • Constipation or obstructed bowel movements – pressure on the rectum.
  • Painful intercourse (dyspareunia) – especially with posteriorly placed fibroids.
  • Reproductive issues – infertility, recurrent pregnancy loss, or preterm labor.
  • Acute pain – when a fibroid outgrows its blood supply (red degeneration) or when a pedunculated fibroid twists (torsion).

Symptoms often fluctuate with the menstrual cycle and may improve after menopause when estrogen levels decline.

Causes and Risk Factors

Exact cause remains unknown, but fibroids are hormone‑dependent (estrogen and progesterone) and involve genetic and environmental factors.

Key contributors

  • Hormonal influence – Estrogen and progesterone promote fibroid growth; they tend to shrink after menopause.
  • Genetic predisposition – First‑degree relatives have a 2–3‑fold higher risk; several gene loci (e.g., HMGA2) have been implicated.
  • Extracellular matrix (ECM) alterations – Overproduction of collagen and other matrix proteins creates a stiff environment that supports tumor growth.

Risk factors

  • Age 30–45 years
  • African‑American ancestry
  • Family history of fibroids
  • Obesity (BMI ≥ 30 kg/m²) – adipose tissue increases peripheral estrogen conversion.
  • Early menarche (< 12 years) and late menopause – longer lifetime estrogen exposure.
  • Nulliparity or low parity – each full‑term pregnancy reduces risk by ~20 %.
  • Diet high in red meat & low in green vegetables and fruit
  • Use of certain hormonal contraceptives (e.g., high‑dose estrogen pills) – data are mixed.3

Diagnosis

Diagnosis begins with a thorough history and pelvic exam, followed by imaging to confirm size, number, and location.

Imaging and tests

  • Transvaginal or transabdominal ultrasound – First‑line, inexpensive, and widely available. Sensitivity > 95 % for detecting fibroids > 2 cm.
  • Magnetic Resonance Imaging (MRI) – Provides detailed mapping, useful for surgical planning or when the ultrasound is inconclusive.
  • Hysterosonography (saline infusion sonography) – Improves visualization of submucosal fibroids.
  • Hysteroscopy – Direct visualization inside the uterine cavity; can also treat protruding submucosal fibroids.
  • Pelvic exam – May feel enlarged, irregular uterus.
  • Blood tests – Complete blood count (CBC) to assess anemia; pregnancy test if childbearing is a possibility.

Treatment Options

Treatment is individualized based on symptom severity, fibroid characteristics, desire for future fertility, age, and overall health.

Medication

  • GnRH agonists (e.g., leuprolide) – Induce a temporary menopausal state, shrinking fibroids 30‑50 % in 3‑6 months. Use limited to 6 months due to bone‑loss risk.
  • Selective progesterone receptor modulators (SPRMs) – ulipristal acetate – Controls bleeding and reduces size; approved in Europe and Canada, FDA approval pending as of 2024.
  • Tranexamic acid – Antifibrinolytic that reduces menstrual blood loss; does not affect fibroid size.
  • Non‑steroidal anti‑inflammatory drugs (NSAIDs) – Provide pain relief but limited impact on bleeding.
  • Low‑dose combined oral contraceptives or levonorgestrel intrauterine system (LNG‑IUS) – Stabilize endometrial lining, reduce menorrhagia.

Surgical & minimally invasive procedures

  • Myomectomy – Removal of fibroids while preserving the uterus; options include hysteroscopic (submucosal), laparoscopic, or open abdominal. Preferred for women desiring future pregnancy.
  • Uterine artery embolization (UAE) – Radiologic occlusion of uterine arteries causing fibroid shrinkage; ~90 % experience symptom relief. Not recommended for women seeking pregnancy.
  • Magnetic resonance‑guided focused ultrasound (MRgFUS) – Non‑invasive ablation using high‑intensity ultrasound waves; limited to select cases.
  • Hysterectomy – Definitive cure; removal of the uterus via abdominal, vaginal, or laparoscopic route. Considered when other therapies fail or in severe cases.
  • Endometrial ablation – Destroys the uterine lining to control bleeding; ineffective for large intramural fibroids and not suitable for women who desire fertility.

Lifestyle & supportive measures

  • Maintain a healthy weight (BMI < 25) – reduces estrogenic drive.
  • Exercise regularly (≥150 min/week) – may lower circulating estrogen.
  • Consume a diet rich in fruits, vegetables, whole grains, and low in red meat.
  • Consider vitamin D supplementation (≥ 400 IU/day) – low vitamin D levels have been linked to fibroid growth.

Living with Uterine Fibroids (Leiomyoma)

Even when treatment is not immediately required, many women benefit from practical strategies to manage symptoms.

Daily management tips

  • Track menstrual flow – Use a period‑tracking app to quantify bleeding and detect changes.
  • Iron‑rich diet – Include lean red meat, legumes, spinach, and fortified cereals; pair with vitamin C for better absorption.
  • Heat therapy – Warm compresses or heating pads can ease cramping.
  • Stress reduction – Yoga, meditation, and deep‑breathing exercises may lower cortisol and indirectly influence estrogen metabolism.
  • Regular follow‑up – Annual ultrasound if fibroids are stable; sooner if symptoms change.
  • Pregnancy planning – Discuss myomectomy timing (usually 3–6 months before conception) with a reproductive specialist.

Prevention

Because the exact cause is unknown, prevention focuses on modifiable risk factors.

  • Maintain a healthy body weight.
  • Adopt a plant‑forward diet low in saturated fats and high in fiber.
  • Engage in regular physical activity.
  • Consider limiting exposure to endocrine‑disrupting chemicals (e.g., BPA in plastics).
  • Discuss hormonal contraceptive options with your provider; low‑dose progestin‑only methods may carry less risk than high‑dose estrogen pills.

Complications

If left untreated, fibroids can lead to several health issues:

  • Severe anemia – from chronic heavy bleeding.
  • Infertility or recurrent miscarriage – especially with submucosal or large intramural fibroids.
  • Pregnancy complications – preterm labor, placental abruption, malpresentation, postpartum hemorrhage.
  • Urinary or bowel obstruction – large posterior fibroids can compress the bladder or rectum.
  • Degeneration – rapid growth may outstrip blood supply, causing pain, fever, and elevated white‑cell count.
  • Rarely, sarcomatous transformation – a malignant change occurs in <0.2 % of fibroids; persistent rapid growth after menopause warrants evaluation.

When to Seek Emergency Care

Call emergency services (911) or go to the nearest emergency department if you experience any of the following:

  • Sudden, severe abdominal or pelvic pain that does not improve with over‑the‑counter pain medication.
  • Heavy bleeding that soaks through a pad or tampon every hour for more than 2 hours.
  • Signs of shock: dizziness, fainting, rapid heartbeat, pale or clammy skin.
  • Fever above 100.4 °F (38 °C) accompanied by pain, indicating possible fibroid degeneration or infection.
  • Sudden inability to urinate or severe difficulty passing stool.

These symptoms may signal torsion, severe degeneration, or significant hemorrhage that requires prompt medical attention.

References

  1. Mayo Clinic. “Uterine fibroids.” Updated 2023. https://www.mayoclinic.org.
  2. CDC. “Uterine fibroids in African‑American women.” 2022. https://www.cdc.gov.
  3. American College of Obstetricians and Gynecologists (ACOG). Practice Bulletin No. 228: “Management of uterine fibroids.” 2021.
  4. NIH National Institute of Child Health and Human Development. “Uterine fibroids research.” 2024.
  5. World Health Organization. “Guidelines for the diagnosis and treatment of uterine fibroids.” 2023.
  6. Cleveland Clinic. “Uterine fibroids: Symptoms, causes, and treatments.” 2023.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References